Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
DiaSorin SpA (DIA IM)
Watchlist
8
Analysis
Health Care
•
Italy
DiaSorin S.p.A. manufactures reagents for in vitro diagnostics.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SD Biosensor
•
24 Mar 2023 06:03
SD Biosensor (137310 KS): COVID Test Revenue Tapering Off; Global Expansion to Drive Future Growth
SD Biosensor is expected to take massive hit in revenue in 2023 due to declining COVID tests. However, new product launches and global expansion...
Tina Banerjee
Follow
531 Views
Share
bullish
•
SD Biosensor
•
16 Oct 2022 09:45
SD Biosensor (137310 KS): Aggressively Investing Windfall Gain From COVID; Adding New Growth Engines
SD Biosensor is pursuing inorganic route to add new business opportunities to navigate the decline in COVID-19 testing demand. Acquisition of...
Tina Banerjee
Follow
303 Views
Share
bullish
•
Seegene Inc
•
14 Oct 2022 15:22
Seegene (096530 KS): Recovery of Non-COVID Sales to Drive Future Growth
Seegene is seeing slow recovery in non-COVID product revenue, with Q2 non-COVID product revenue increasing 21% q/q. At the current level Seegene...
Tina Banerjee
Follow
366 Views
Share
bullish
•
Becton Dickinson and Co
•
30 Nov 2020 11:48
Biden COVID-19 Response Plan: Its Largest Near-Term Opportunity Is In Testing Stocks
COVID-19 testing stocks represent the largest, most tangible, and nearest-term investment opportunity inherent in Biden's recently-announced COVID...
Kyle Rudden
Follow
316 Views
Share
bullish
•
Abbott Laboratories
•
30 Nov 2020 11:43
Biden COVID-19 Response Plan: Overview of Its Inherent Investment Themes
Biden's recently-announced COVID-19 response plan suggests a number of investment themes. This Insight overviews the more significant of those...
Kyle Rudden
Follow
253 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x